Skip to main content

Please note that this is a beta version of our website. Should you encounter any bugs, glitches, lack of functionality or other problems on the website, please let us know immediately so we can rectify these accordingly. Your help in this regard is greatly appreciated! You can email us.

Login to North West London Pathology – consumables service

If you need a new account or you have a query about your order, please telephone the pathology call centre on 0203 313 5353.

If you have forgotten your password you can reset this yourself. Please click here if you have forgotten your password.

Results Line and Enquiries

0203 313 5353

Anti-TNF drug levels Anti- TNF drug neutralising antibodies (Infliximab IFX, Adalimumab ADA, Etanercept ETA, Vedolizumab VEDL)

Category Immunology
Test background

A significant proportion of patients treated with anti-TNF therapy are primary non-responders and require dose- or dose frequency adjustments. The lack of response to treatment has also been attributed to immunogenicity and the development of anti-drug neutralising antibodies. Studies have shown that response rates increase with infliximab trough concentration and serum drug levels at 4 weeks post-infusion in some patients are positively correlated with duration of response. However the probability of an infection increases with the number of anti-TNF infusions. Anti-TNF drugs can therefore be considered to have a narrow therapeutic index and drug monitoring based on serum trough levels together with monitoring for anti-drug antibodies (neutralising antibodies) may improve clinical treatment decisions.

An in-house ELISA assay is used to measure serum trough drug levels. Neutralising antibodies are measured using the ILite NAb bioassay (BioMonitor) which detects antibodies in serum with the ability to neutralise anti-TNF drugs.

Clinicial Indications

For the monitoring of patients treated with Infliximab, Adalimumab, or Etanercept. (Please note we will only measure neutralising antibodies when drug trough levels are below 1.2 ug/ml).

Reference range

NA

Sample & container required Serum - RST (rust top gel)
Sample volume 5ml
Sample collection

Perform venesection BEFORE next drug infusion

Transport storage Room temperature
Turnaround time Drug levels = 2 weeks
Neutralising antibodies = 4 weeks